Table 2 Substance use characteristics and syringe acquisition/disposal in study participants, stratified by syringe service program use
From: Injections and infections: understanding syringe service program utilization in a rural state
Overall n = 101 (%) | SSP usea n = 65 (%) | No SSP use n = 36 (%) | p valueb | |
|---|---|---|---|---|
Substance use characteristics | ||||
Drug use severity (mean SIP-DUc (standard deviation)) | 33 (12) | 33 (12) | 32 (13) | 0.71 |
Unhealthy alcohol use (positive AUDIT-C score)d | 31 (31%) | 17 (26%) | 14 (39%) | 0.20 |
Skin infection risk (median BIRSI-7 scoree) | 3.8 (1.6) | 3.75 (1.5) | 3.81 (1.8) | 0.88 |
Injection drugs of choice | 0.03 | |||
Heroin | 39 (40%) | 32 (49%) | 7 (21%) | |
Fentanyl | 14 (14%) | 7 (11%) | 7 (21%) | |
Cocaine | 11 (11%) | 7 (11%) | 4 (12%) | |
Amphetamine | 11 (11%) | 9 (14%) | 2 (6%) | |
Buprenorphine | 8 (8%) | 3 (5%) | 5 (15%) | |
Speedball (cocaine + heroin) | 9 (9%) | 5 (8%) | 4 (12%) | |
Other | 6 (6%) | 2 (3%) | 4 (12%) | |
History of overdose | 54 (53%) | 42 (65%) | 12 (33%) | < 0.01 |
MOUDf before admission | 67 (66%) | 46 (71%) | 21 (58%) | 0.20 |
Naloxone uptake | 48 (48%) | 36 (55%) | 12 (33%) | 0.03 |
Injected alone 30 days prior to hospitalization | 89 (91%) | 60(92%) | 29 (88%) | 0.50 |
Syringe acquisition and disposal | ||||
Used new needle always/most of the time | 42 (42%) | 34 (52%) | 8 (22%) | 0.05 |
Used clean works (cookers, filters) always/most of the time | 24 (24%) | 20 (31%) | 4 (11%) | 0.04 |
Where needles acquiredg | < 0.01 | |||
SSP | 39 (39%) | 38 (59%) | 1 (3%) | |
Pharmacy | 51 (51%) | 23 (35%) | 28 (80%) | |
Peer exchange | 9 (9%) | 3 (5%) | 6 (17%) | |
Interest in mobile harm reduction unit | 97 (97%) | 65 (100%) | 32 (91%) | 0.04 |
Interest in supervised injection facility | 93 (93%) | 62 (95%) | 31 (89%) | 0.24 |